
Cagrilintide
Long-acting amylin analogue supporting appetite regulation and metabolic balance.
Cagrilintide
Cagrilintide is a long-acting amylin receptor agonist engineered with structural modifications that confer resistance to enzymatic degradation and enable albumin binding, dramatically extending its half-life compared to native amylin or Pramlintide. It is particularly notable for its effects on appetite reduction and body weight regulation, especially in combination with GLP-1 receptor agonists.
How It Works
Cagrilintide activates amylin receptors (AMY1, AMY2, AMY3) with sustained activity due to its extended half-life:
• Sustained Amylin Receptor Activation:: Long-acting profile enables sustained amylin receptor activation, supporting chronic appetite and glucose regulation
• Central Satiety:: Activates amylin receptors in the area postrema and nucleus tractus solitarius, producing sustained satiety and reduced food intake
• Glucagon Suppression:: Sustained amylin receptor activation suppresses postprandial glucagon secretion
• Gastric Emptying Modulation:: Slows gastric emptying through amylin receptor-mediated mechanisms
• Combination Synergy:: Works synergistically with GLP-1R agonists (particularly Semaglutide) for additive appetite suppression and weight management — the CagriSema combination
Key Benefits
• Powerful Appetite Suppression:: Long-acting amylin receptor activation for sustained satiety
• Weight Management:: Supports significant body weight reduction, especially in combination with GLP-1R agonists
• Glucose Balance:: Suppresses postprandial glucagon for better glucose regulation
• Long-Acting:: Extended half-life for convenient, less frequent dosing
Structural Properties
Cagrilintide includes amino acid substitutions preventing amyloid fibril formation and a fatty acid chain enabling albumin binding. Purity ≥97.0%.
Quality and Purity
Supplied as a lyophilized powder with purity ≥97.0% verified by HPLC and mass spectrometry. Each vial contains 5 mg.
Storage
Store at −80°C. Stable for 12 months.
Product Details
Storage & Handling
Store at -80°C.
Related Products

Retatrutide
Triple GIP/GLP-1/glucagon receptor agonist for advanced metabolic support and body composition.

Orforglipron (Research)
Non-peptide oral GLP-1 receptor agonist for advanced metabolic wellness.